Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
60.03%
Near historical average
Percentile
P86
Within normal range
Streak
1 qtr
Consecutive growthStable
Average
54.99%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 60.03% |
| Q3 2025 | 19.89% |
| Q2 2025 | 25.83% |
| Q1 2025 | 18.93% |
| Q4 2024 | 939.45% |
| Q3 2024 | -143.27% |
| Q2 2024 | 29.62% |
| Q1 2024 | -7.82% |
| Q4 2023 | -74.54% |
| Q3 2023 | 553.81% |
| Q2 2023 | 12.28% |
| Q1 2023 | 63.14% |
| Q4 2022 | -118.66% |
| Q3 2022 | 893.11% |
| Q2 2022 | 78.77% |
| Q1 2022 | -95.12% |
| Q4 2021 | 33.76% |
| Q3 2021 | 26.49% |
| Q2 2021 | 3.34% |
| Q1 2021 | 2.60% |
| Q4 2020 | -20.02% |
| Q3 2020 | -17.44% |
| Q2 2020 | 8.09% |
| Q1 2020 | -31.55% |
| Q4 2019 | 17.42% |
| Q3 2019 | 29.77% |
| Q2 2019 | 34.12% |
| Q1 2019 | -128.87% |
| Q4 2018 | -34.92% |
| Q3 2018 | -14.33% |
| Q2 2018 | -19.67% |
| Q1 2018 | 35.96% |
| Q4 2017 | -113.64% |
| Q3 2017 | -7.10% |
| Q2 2017 | -79.93% |
| Q1 2017 | 0.00% |